Top Journalists
>
Mohit Manghnani

Mohit Manghnani

Author at benzinga.com at Benzinga

Contact this person
Email address
m*****@*******.comGet email address
Influence score
24
Location
United States
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to AI PR

    View latest data and reach out all from one place
    Sign up to AI PR Toolkit

    Recent Articles

    benzinga.com

    EXCLUSIVE: FibroBiologics Doses First Patients In Diabetic Foot Ulcers Clinical Trial

    FibroBiologics Inc. (NASDAQ: FBLG) reports enrolling first patients in its Phase 1/2 trial for CYWC628, a fibroblast-based therapy targeting diabetic foot ulcers.
    benzinga.com

    EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease ...

    TransCode Therapeutics announced successful completion of Phase 1a clinical trial for TTX-MC138, showing safety and disease stabilization in patients with advanced cancer.
    benzinga.com

    How Did Ford Perform In 2025? - Ford Motor (NYSE:F)

    How Did Ford Perform In 2025? - Ford Motor (NYSE:F)
    benzinga.com

    Top Large Cap Stock Gainers - AST SpaceMobile (NASDAQ:ASTS), CoreWe...

    Investor optimism fuels stock market with strong earnings and projections from tech sectors like semiconductors, AI, and cloud computing.
    benzinga.com

    Top Large Cap Losers Last Week - Paramount Skydance (NASDAQ:PSKY), ...

    Volatility in stock prices driven by company-specific and industry trends led to significant losses for large-cap stocks in the last week.
    benzinga.com

    EXCLUSIVE: Co-Diagnostics Inks JV With Saudi Arabia Firm For Middle...

    Co-Diagnostics (Nasdaq: CODX) entered a joint venture with Arabian Eagle Manufacturing to develop and commercialize Co-Dx technologies in Saudi Arabia and other Middle East and North Africa countries.
    benzinga.com

    Coinbase Flywheel Is Coming: Analyst - Coinbase Global (NASDAQ:COIN)

    Coinbase (COIN) is a leading digital asset exchange with $404B in assets and 8.4M monthly users. BTIG initiates coverage with Buy rating.
    benzinga.com

    EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements ...

    Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare institutions and plans to expand further.
    benzinga.com

    What's Going On With DoorDash Stock Wednesday? - DoorDash (NASDAQ:D...

    DASH expands Commerce Platform with new tools for restaurants to increase sales and improve customer relationships. Includes loyalty and marketing programs, website creation, and CRM tools. Packages start at $0.
    benzinga.com

    Top Large Cap Losers Last Week - Centene (NYSE:CNC), Circle Interne...

    10 worst performing large-cap stocks in holiday-shortened week, including Centene Corp, Molina Healthcare, and Circle Internet Group.
    benzinga.com

    Top Large Cap Gainers Last Week - Datadog (NASDAQ:DDOG), Nike (NYSE...

    11 best performing large-cap stocks last week, including Symbotic, Nike, First Solar, Datadog, HPE, Summit Therapeutics, Carnival, POSCO, Wynn Resorts, SharkNinja, and Snap